Cervical cancer screening in India: tests, consent, results and follow-up
A practical guide for women on cervical screening, HPV tests, VIA, privacy, informed consent and what to do after an abnormal result in India.
In this guide
Screening is for people without symptoms
Cervical screening looks for HPV infection or cervical cell changes before cancer develops. It is different from testing a symptom, and an abnormal screen does not mean a person has cancer.
Do not wait for a screening appointment if you have symptoms
Bleeding after sex, bleeding between periods or after menopause, persistent unusual discharge or ongoing pelvic pain needs clinical assessment. Screening alone cannot diagnose the cause of a symptom.
Ask which test the service offers
Methods may include HPV testing, visual inspection with acetic acid (VIA) or cytology, depending on the programme and facility. The Government of India’s common-cancer guidance describes public-programme screening for women over 30; local services may follow updated protocols.
Global guidance and Indian delivery can differ
WHO’s 2026 guidance discusses HPV DNA tests and risk-based follow-up. A local public clinic may have different tests and referral capacity, so ask what protocol it currently uses and where a positive result is managed.
Vaccination does not remove the need for screening
HPV vaccination prevents important infections but does not cover every cancer-causing type. Ask a clinician or local programme about the screening schedule that applies to you.
A screening result is one step
A positive or unclear result usually needs triage, repeat testing, examination or referral. Ask how and when results will reach you and who will explain the next step.
Choose a service and understand the test
Before a test, the provider should explain what sample or examination is planned, why it is being offered, how it may feel, how results are handled and what follow-up is available.
Ask whether the test is HPV, VIA or another method
The technique affects what happens during the visit and how the result is interpreted. Request an explanation in your preferred language before agreeing.
Ask where results and follow-up are available
Find out the expected result date, safe contact method, referral facility, cost and who can help book the next visit. A screening programme works only when people can complete follow-up.
Ask about privacy and a support person
You can ask who will be in the room, whether a chaperone is available, how your record is stored and whether a person you choose can accompany you. A supporter should not answer in your place.
Ask whether self-collected HPV sampling is offered
WHO supports self-collection as an option in appropriate HPV screening settings, but it may not be available through every Indian service. Ask how a sample is collected, processed and followed up.
Plan around access needs
Request a ramp, adjustable examination table, interpreter, more time, trauma-informed care, a female provider where available or help with transport. Tell the clinic what makes the visit workable for you.
| Question | What the clinic confirms | Safe contact and next date |
|---|---|---|
| Which test and why? | ||
| How and when will results arrive? | ||
| Where is follow-up available? | ||
| What privacy or access support do I need? |
Consent, comfort and control during the visit
A screening test is a healthcare procedure. A woman can ask for information, a pause or a different arrangement; consent to one step does not automatically cover another.
Know what the provider plans to do
Ask whether a speculum, swab, visual examination or another procedure is planned, why it is needed and whether there are alternatives. Ask who will perform each step.
You can ask to stop or pause
Tell the provider if you are in pain, frightened or need a break. Ask for a smaller instrument, more explanation or another appointment if clinically appropriate.
A supporter is your choice
You may bring a trusted person or ask the provider to speak with you alone. Family, a partner or an employer does not own the decision or the result.
Ask what happens if you decline today
For a non-emergency screening decision, ask about risks, alternatives and when to return. You can take time to decide; a provider should not shame or threaten you into a test.
Request records and an explanation
Ask how to obtain the result, referral note and any report. The patient-rights charter describes access to relevant information and records; facility processes can vary.
Understand an abnormal result and complete follow-up
An abnormal screen means the service found a result that needs another step. It does not by itself confirm cancer, and delaying follow-up can leave a treatable precancerous change unaddressed.
Ask the provider to name the exact result
Ask whether HPV was detected, what cell or visual change was seen, what the risk category means and whether the result needs repeat testing, triage, colposcopy, biopsy or treatment.
Get a dated referral plan
Write down where to go, who to ask for, the expected date, cost and transport. If the first facility cannot offer care, ask it to identify a receiving centre and send the record.
Do not treat HPV as proof of infidelity
HPV can remain undetected for a long time and is common. A result cannot establish when it was acquired or accuse a partner. Ask a clinician to explain what it means for care.
Keep the report private
Use a safe phone number or email, ask who can see results and avoid forwarding them to relatives or work unless you choose. A diagnosis should not become a source of control or blame.
Seek another explanation if you are unsure
Ask for a second opinion or copies of the slides and reports where available. Keep the original referral and note every appointment or call.
Make screening accessible and respectful
Access depends on distance, cost, disability accommodation, language, childcare, privacy and the availability of follow-up. Clinics and programmes should make these barriers visible and respond to them.
Ask about public services and charges
A government health facility, local health worker or district programme may identify a screening site. Confirm the test, cost and referral before travelling; services differ by area.
Request disability and communication support
Tell the service what equipment, position, interpreter, reader or extra time would help. A woman should not be refused without a discussion of a safe alternative.
Arrange childcare or a safe return trip
Ask whether appointments can be combined, what visit length to expect, whether a child may accompany you and what transport is available after a procedure.
Use a grievance channel for coercion or humiliation
If a test is performed without consent, private details are disclosed or a service refuses an accessible arrangement, ask for the facility grievance contact and keep a safe record.
Get urgent help for violence or medical danger
Call 112 for immediate danger. Women Helpline 181 and One Stop Centres may connect medical, counselling, shelter or legal support.
Questions people ask
At what age should I start screening in India?
WHO recommends high-performance screening beginning at age 30 for the general population; Indian public-programme materials describe screening for women over 30. Your interval and method depend on the current national or local protocol and personal risk.
Does an abnormal result mean I have cancer?
No. Screening identifies a result that may need triage or diagnostic assessment. Ask which next test confirms what is happening.
Can I say no or ask to stop?
You can ask for an explanation, pause or alternative. Tell the provider what you are comfortable with and ask what follow-up is safe if you defer the test.
Can I be screened if I received the HPV vaccine?
Yes, vaccination does not cover every cancer-causing HPV type. Follow the current screening recommendation for your age and history.
What can a supporter say?
‘You deserve to know what the test involves and what happens to your result. I can come with you if you want, and you can ask questions or pause at any point.’
Related practical guides
Related issue guides
Sources and publication record
Draft prepared 25 September 2026; project-team editorial review pending · Sources checked .
- WHO guideline on cervical pre-cancer screening and treatment: HPV DNA genotyping (2026)World Health Organization
- Operational Guidelines on Prevention, Screening and Control of Common Non-Communicable DiseasesNational Health Mission, Ministry of Health and Family Welfare, Government of India
- Charter of Patients’ Rights and ResponsibilitiesMinistry of Health and Family Welfare, Government of India
- Justice K.S. Puttaswamy (Retd.) v. Union of India, Supreme Court judgment (24 August 2017)Supreme Court of India
- Rights of Persons with Disabilities Act, 2016India Code, Legislative Department
- Legal Services Authorities Act, 1987India Code, Legislative Department
- Free legal services and National Legal Aid Helpline 15100National Legal Services Authority
- Emergency Response Support System 112Ministry of Home Affairs
- Women Helpline 181Ministry of Women and Child Development
- One Stop Centre schemeMinistry of Women and Child Development